Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 133.08%464.9M | 60.44%537.44M | -64.35%392.04M | -46.23%637.19M | -81.18%199.46M | -67.60%334.97M | -0.89%1.1B | 9.96%1.19B | 2,097.72%1.06B | 1,574.40%1.03B |
| Transactional financial assets | -40.04%340.17M | -67.28%170.3M | 6,390.37%331.37M | 4,087.67%211.38M | --567.32M | --520.55M | --5.11M | --5.05M | ---- | ---- |
| Notes receivable and accounts receivable | 24.89%951.86M | 27.43%981.83M | 35.67%922.93M | 47.10%844.44M | 29.51%762.15M | 40.41%770.51M | 38.18%680.26M | 6.22%574.06M | 13.58%588.5M | 2.94%548.75M |
| -Notes receivable | -34.00%107.06M | -20.30%116.57M | 12.26%146.72M | 22.58%164.2M | 22.56%162.2M | 31.40%146.26M | 11.23%130.69M | -24.22%133.96M | -37.87%132.34M | -46.31%111.31M |
| -Accounts receivable | 40.81%844.8M | 38.61%865.26M | 41.24%776.22M | 54.57%680.23M | 31.52%599.95M | 42.71%624.25M | 46.64%549.57M | 21.02%440.09M | 49.50%456.15M | 34.27%437.44M |
| Other receivables (including interest and dividends) | 111.83%16.91M | -3.74%14.13M | 86.28%9.85M | -41.80%10.3M | 78.58%7.98M | 250.98%14.68M | 9.68%5.29M | 399.35%17.7M | 1.07%4.47M | 11.26%4.18M |
| -Dividend receivable | ---- | ---- | --1.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other receivable | ---- | -3.74%14.13M | ---- | ---- | ---- | 250.98%14.68M | ---- | 399.35%17.7M | ---- | 11.26%4.18M |
| Advance payment | 151.82%8.6M | 135.83%5.53M | 94.07%5.2M | 16.85%3.09M | -43.57%3.42M | -33.81%2.35M | -19.37%2.68M | 36.27%2.64M | 72.54%6.05M | 76.25%3.54M |
| Inventories | 7.79%257.33M | 13.96%229.27M | 22.43%269.67M | 45.82%301.72M | 35.33%238.73M | 28.70%201.19M | 25.66%220.26M | 25.31%206.92M | 8.82%176.4M | 2.11%156.32M |
| Receivable financing | -34.81%36.27M | -0.59%33.78M | 51.97%62.98M | 28.16%31.83M | 12.84%55.64M | -48.14%33.98M | -4.68%41.44M | -12.47%24.83M | 50.08%49.31M | 178.09%65.51M |
| Other current assets | 179.54%4.95M | 206.98%3.8M | -23.09%3.34M | -13.50%3.15M | 83.53%1.77M | 39.01%1.24M | -45.66%4.34M | -70.81%3.65M | -62.65%964.37K | 362.29%890.18K |
| Total current assets | 13.32%2.08B | 5.14%1.98B | -3.00%2B | 1.15%2.04B | -2.59%1.84B | 3.67%1.88B | 12.11%2.06B | 10.40%2.02B | 144.26%1.89B | 133.19%1.81B |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | --138.43M | --80.14M | ---- | ---- | ---- | ---- |
| Investment real estate | ---- | -10.27%2.7M | -9.06%2.79M | -8.02%2.89M | -7.46%2.98M | -8.54%3.01M | -8.77%3.07M | -8.87%3.14M | -8.68%3.22M | -8.50%3.29M |
| Long-term equity investment | 3,910.44%41.88M | 3,721.37%40.94M | 648.89%8.43M | --1.04M | --1.04M | --1.07M | --1.13M | ---- | ---- | ---- |
| Fixed assets | ---- | 17.92%223.76M | ---- | ---- | ---- | 4.89%189.76M | ---- | 8.92%184.08M | ---- | 20.19%180.92M |
| Constru in process | ---- | 303.25%195.88M | ---- | ---- | ---- | 322.51%48.58M | ---- | -45.64%14.82M | ---- | 1.45%11.5M |
| Intangible assets | -0.88%121.26M | 47.37%122.47M | 47.51%123.67M | 348.71%124.94M | 372.71%122.34M | 235.68%83.1M | 232.86%83.84M | 8.81%27.85M | 29.91%25.88M | 22.69%24.76M |
| Long deferred expense | -95.18%83.08K | -32.31%545.36K | -14.64%835.98K | 12.34%423.11K | 255.08%1.72M | 35.45%805.67K | 63.14%979.33K | -45.48%376.64K | -38.98%485.73K | 82.31%594.82K |
| Deferred tax assets | 62.84%11M | 46.62%10.13M | 60.30%9.31M | 83.62%8.87M | 37.59%6.76M | 55.07%6.91M | 28.51%5.81M | 8.02%4.83M | 0.20%4.91M | -9.88%4.45M |
| Usufruct assets | -39.96%8.24M | -34.70%9.48M | -29.89%11.3M | 17.33%15.8M | 10.16%13.73M | 7.04%14.51M | 7.75%16.11M | -16.99%13.46M | -4.12%12.46M | 70.88%13.56M |
| Other non current assets | 625.79%51.66M | 541.63%34.8M | 935.58%191.47M | 3,560.45%141.24M | -13.09%7.12M | 101.96%5.42M | 330.50%18.49M | 179.53%3.86M | -19.57%8.19M | -46.24%2.69M |
| Total non current assets | 30.77%711.45M | 47.86%640.7M | 108.69%701.98M | 139.88%605.5M | 121.49%544.03M | 79.24%433.31M | 37.62%336.38M | 1.75%252.42M | 10.44%245.62M | 18.60%241.75M |
| Total assets | 17.30%2.79B | 13.15%2.62B | 12.68%2.7B | 16.56%2.65B | 11.71%2.38B | 12.56%2.31B | 15.10%2.4B | 9.37%2.27B | 114.33%2.13B | 109.39%2.05B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 121.71%75.93M | 109.72%58.92M | -17.12%44.69M | 27.45%44.18M | 14.77%34.25M | 118.26%28.1M | 473.92%53.92M | 4.26%34.67M | -5.62%29.84M | -57.18%12.87M |
| Notes payable and accounts payable | 29.67%572.87M | 22.67%547.79M | 28.05%566.7M | 66.09%608.88M | 60.99%441.8M | 70.93%446.57M | 76.24%442.57M | 80.69%366.6M | 50.70%274.43M | 33.81%261.26M |
| -Notes payable | -1.06%172.9M | -6.96%172.76M | 16.97%208.5M | 53.09%198.27M | 173.08%174.75M | 207.67%185.68M | 225.73%178.25M | 195.13%129.51M | 34.47%63.99M | 22.18%60.35M |
| -Accounts payable | 49.77%399.97M | 43.75%375.03M | 35.51%358.19M | 73.19%410.62M | 26.90%267.05M | 29.85%260.89M | 34.59%264.33M | 49.11%237.09M | 56.45%210.44M | 37.75%200.91M |
| Contract liabilities | 5.61%3.69M | 23.52%2.86M | -19.49%3.74M | 17.40%4.63M | 38.84%3.5M | 12.25%2.32M | 65.33%4.65M | -1.20%3.94M | -21.62%2.52M | -7.02%2.07M |
| Advance receipts | ---- | ---- | ---- | -72.85%565K | -10.34%520.24K | -5.45%1.04M | -2.77%1.58M | -2.80%2.08M | 2.61%580.24K | 1.36%1.1M |
| Salaries payable | 7.84%25.54M | 9.71%21.87M | -8.24%17.09M | 32.74%31.96M | 29.36%23.69M | 19.41%19.93M | 18.92%18.63M | 20.74%24.08M | 31.26%18.31M | 32.39%16.69M |
| Taxs payable | 41.99%26.37M | -11.95%22.07M | 39.88%31.53M | 146.68%32.83M | 22.81%18.57M | 92.22%25.06M | 87.35%22.54M | -47.21%13.31M | -32.32%15.12M | -52.18%13.04M |
| Other payable (including interest and dividends) | 8.67%2.99M | -19.84%3.02M | 201.61%7.86M | 27.27%3.18M | 5.03%2.75M | 223.29%3.76M | 107.11%2.61M | -74.28%2.5M | -65.80%2.62M | -78.61%1.16M |
| -Dividend payable | --1.08M | -17.24%1.08M | ---- | --1.31M | ---- | --1.31M | ---- | ---- | ---- | ---- |
| -Other payable | ---- | -21.22%1.94M | ---- | ---- | ---- | 111.21%2.46M | ---- | -74.28%2.5M | ---- | -78.61%1.16M |
| Non current liabilities due within one year | 9.38%4.97M | 16.23%4.78M | -7.37%4.36M | 21.71%4.86M | -8.21%4.55M | -19.00%4.11M | -18.07%4.71M | -20.94%3.99M | --4.95M | --5.08M |
| Other current liabilities | 19.38%34.26M | 19.09%32.48M | 64.16%39.89M | 50.86%38.91M | -6.03%28.7M | 11.24%27.28M | -40.11%24.3M | -62.90%25.79M | -58.31%30.54M | -65.16%24.52M |
| Total current liabilities | 33.73%746.64M | 24.30%693.79M | 24.39%715.87M | 61.44%770M | 47.34%558.33M | 65.24%558.17M | 69.16%575.5M | 28.31%476.96M | 13.21%378.92M | -1.89%337.79M |
| Current liabilities | ||||||||||
| Long term loan | --111.78M | --65.89M | --46.73M | --1M | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | ---- | ---- | -75.36%1.86M | -71.17%2.34M | -33.62%5.55M | -21.72%7.24M | -27.57%7.56M | 11.26%8.12M | 28.52%8.36M | 43.80%9.24M |
| Long term deferred income | -16.57%9.87M | 376.01%10.67M | 382.04%11.5M | 390.73%12.42M | 342.15%11.83M | -20.52%2.24M | -19.52%2.39M | -18.61%2.53M | -17.79%2.68M | -17.03%2.82M |
| Lease liabilities | -51.57%4.37M | -46.02%5.24M | -39.06%6.24M | 36.26%10.54M | 20.63%9.03M | 21.83%9.7M | 9.98%10.24M | -22.68%7.73M | -43.14%7.48M | -1.02%7.96M |
| Total non current liabilities | 377.25%126.02M | 326.53%81.8M | 228.56%66.34M | 43.08%26.3M | 42.60%26.41M | -4.24%19.18M | -11.13%20.19M | -9.93%18.38M | -19.21%18.52M | 12.06%20.03M |
| Total liabilities | 49.24%872.66M | 34.34%775.59M | 31.31%782.21M | 60.76%796.3M | 47.12%584.73M | 61.35%577.35M | 64.13%595.69M | 26.32%495.34M | 11.13%397.44M | -1.21%357.82M |
| Shareholders equity | ||||||||||
| Paid-in capital | 40.00%136.78M | 40.00%136.78M | 0.00%97.7M | 0.00%97.7M | 0.00%97.7M | 0.00%97.7M | 50.00%97.7M | 50.00%97.7M | 100.00%97.7M | 100.00%97.7M |
| Capital reserve funds | -2.63%1.06B | -4.05%1.06B | -0.94%1.09B | -0.90%1.09B | -1.16%1.09B | 0.00%1.1B | -2.87%1.1B | -2.87%1.1B | 713.99%1.1B | 713.99%1.1B |
| Surplus reserve funds | 35.14%66.45M | 35.14%66.45M | 35.14%66.45M | 35.14%66.45M | 40.50%49.17M | 40.50%49.17M | 40.50%49.17M | 40.50%49.17M | 0.00%35M | 0.00%35M |
| Retained profit | 14.75%600.6M | 8.39%528.03M | 14.61%610.67M | 14.82%556.75M | 13.89%523.41M | 14.12%487.16M | 17.90%532.82M | 16.21%484.88M | 18.19%459.56M | 14.17%426.88M |
| Less:Treasury stock | ---- | ---- | ---- | --7.44M | --7.44M | --41.78M | --22.25M | ---- | ---- | ---- |
| Shareholders equity without minority interests | 6.40%1.87B | 5.56%1.79B | 6.07%1.87B | 4.13%1.81B | 3.41%1.75B | 1.96%1.7B | 4.31%1.76B | 4.95%1.74B | 178.84%1.7B | 180.35%1.66B |
| Minority interests | 28.04%53.41M | 29.40%50.69M | 26.79%48.76M | 8.78%44.8M | 12.09%41.71M | 17.57%39.17M | 29.47%38.46M | 30.26%41.18M | 31.58%37.22M | 29.53%33.32M |
| Total shareholder equity | 6.91%1.92B | 6.10%1.84B | 6.52%1.92B | 4.24%1.85B | 3.59%1.8B | 2.27%1.74B | 4.75%1.8B | 5.42%1.78B | 172.30%1.73B | 174.09%1.7B |
| Total liabilityies and equity | 17.30%2.79B | 13.15%2.62B | 12.68%2.7B | 16.56%2.65B | 11.71%2.38B | 12.56%2.31B | 15.10%2.4B | 9.37%2.27B | 114.33%2.13B | 109.39%2.05B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.